Specific loss of Toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice

Author： Hasu Mirela Thabet Mohamed Tam Nancy Whitman Stewart C.

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.89, Iss.10, 2011-10, pp. : 737-742

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Toll of Toll-Like Receptors, Especially Toll-Like Receptor 2, on Murine Atherosclerosis

Current Drug Targets, Vol. 8, Iss. 12, 2007-12 ,pp. : 1230-1238

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands

Current Drug Delivery, Vol. 14, Iss. 7, 2017-10 ,pp. : 935-943

Bentham Science Publishers

Access to resources Recommend Favorite

Albumin Induces Neuroprotection Against Ischemic Stroke by Altering Toll-Like Receptor 4 and Regulatory T Cells in Mice

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 220-227

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion

Medicinal Chemistry, Vol. 13, Iss. 6, 2017-08 ,pp. : 569-576

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of 15-deoxy- 12,14 prostaglandin J 2 and interluekin-4 in Toll-like receptor-4-mutant glial cells

By Kitamura Y. Kakimura J.-i. Koike H. Umeki M. Gebicke-Haerter P.J. Nomura Y. Taniguchi T.

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite